Europe Diabetes Insulin Pen Market Report 2019

  • Report Code : 322822
  • Pages : 115
  • Published On : Feb 2020
  • Industry : Healthcare and Pharmaceuticals
  • Format :

Choose License Type

Single User License: US$ 3,450
Multi User License: US$ 0
Corporate User License: US$ 6,800
In this report, the Diabetes Insulin Pen market is expected to be valued at USD xxx billion by 2026, growing at a CAGR of xx% between 2020 and 2026. In this study, sales and sales value (million USD) of major players in Europe market will be included.
Sales and revenue by type/application from 2014-2026.
Industry chain, market trend, downstream and upstream information is also included.

Geographically, this report split Europe into several key Regions, with sales (K Units), revenue (Million USD), market share and growth rate of Diabetes Insulin Pen for these regions, from 2014 to 2026 (forecast), including
Germany
UK
France
Russia
Benelux
Italy
Spain

Europe Diabetes Insulin Pen market competition by top manufacturers/players, with Diabetes Insulin Pen sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
BD
Novo Nordisk
Artsana
B. Braun
Terumo
Ypsomed
Owen Mumford
HTL-Strefa
Beipu
Kangdelai
Ulticare
Allison Medical
Dongbao

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into
Disposable Diabetes Insulin Pen
Reusable Diabetes Insulin Pen

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Diabetes Insulin Pen for each application, including
Hospital
Household

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Diabetes Insulin Pen Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Disposable Diabetes Insulin Pen Market Performance (Volume)
2.1.2 Reusable Diabetes Insulin Pen Market Performance (Volume)
2.2 Overall Market Performance(Value)
2.2.1 Disposable Diabetes Insulin Pen Market Performance (Value)
2.2.2 Reusable Diabetes Insulin Pen Market Performance (Value)
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Hospital Market Performance (Volume)
3.1.2 Household Market Performance (Volume)
4 Manufacturers Profiles/Analysis
4.1 BD
4.1.1 BD Profiles
4.1.2 BD Product Information
4.1.3 BD Diabetes Insulin Pen Business Performance
4.1.4 BD Diabetes Insulin Pen Business Development and Market Status
4.2 Novo Nordisk
4.2.1 Novo Nordisk Profiles
4.2.2 Novo Nordisk Product Information
4.2.3 Novo Nordisk Diabetes Insulin Pen Business Performance
4.2.4 Novo Nordisk Diabetes Insulin Pen Business Development and Market Status
4.3 Artsana
4.3.1 Artsana Profiles
4.3.2 Artsana Product Information
4.3.3 Artsana Diabetes Insulin Pen Business Performance
4.3.4 Artsana Diabetes Insulin Pen Business Development and Market Status
4.4 B. Braun
4.4.1 B. Braun Profiles
4.4.2 B. Braun Product Information
4.4.3 B. Braun Diabetes Insulin Pen Business Performance
4.4.4 B. Braun Diabetes Insulin Pen Business Development and Market Status
4.5 Terumo
4.5.1 Terumo Profiles
4.5.2 Terumo Product Information
4.5.3 Terumo Diabetes Insulin Pen Business Performance
4.5.4 Terumo Diabetes Insulin Pen Business Development and Market Status
4.6 Ypsomed
4.6.1 Ypsomed Profiles
4.6.2 Ypsomed Product Information
4.6.3 Ypsomed Diabetes Insulin Pen Business Performance
4.6.4 Ypsomed Diabetes Insulin Pen Business Development and Market Status
4.7 Owen Mumford
4.7.1 Owen Mumford Profiles
4.7.2 Owen Mumford Product Information
4.7.3 Owen Mumford Diabetes Insulin Pen Business Performance
4.7.4 Owen Mumford Diabetes Insulin Pen Business Development and Market Status
4.8 HTL-Strefa
4.8.1 HTL-Strefa Profiles
4.8.2 HTL-Strefa Product Information
4.8.3 HTL-Strefa Diabetes Insulin Pen Business Performance
4.8.4 HTL-Strefa Diabetes Insulin Pen Business Development and Market Status
4.9 Beipu
4.9.1 Beipu Profiles
4.9.2 Beipu Product Information
4.9.3 Beipu Diabetes Insulin Pen Business Performance
4.9.4 Beipu Diabetes Insulin Pen Business Development and Market Status
4.10 Kangdelai
4.10.1 Kangdelai Profiles
4.10.2 Kangdelai Product Information
4.10.3 Kangdelai Diabetes Insulin Pen Business Performance
4.10.4 Kangdelai Diabetes Insulin Pen Business Development and Market Status
4.11 Ulticare
4.12 Allison Medical
4.13 Dongbao
5 Market Performance for Manufacturers
5.1 Europe Diabetes Insulin Pen Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Europe Diabetes Insulin Pen Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Europe Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
5.4 Europe Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 Germany Market Performance for Manufacturers
6.1.1 Germany Diabetes Insulin Pen Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 Germany Diabetes Insulin Pen Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 Germany Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 Germany Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 UK Market Performance for Manufacturers
6.2.1 UK Diabetes Insulin Pen Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 UK Diabetes Insulin Pen Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 UK Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 UK Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 France Market Performance for Manufacturers
6.3.1 France Diabetes Insulin Pen Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 France Diabetes Insulin Pen Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 France Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 France Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Russia Market Performance for Manufacturers
6.4.1 Russia Diabetes Insulin Pen Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Russia Diabetes Insulin Pen Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Russia Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Russia Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Benelux Market Performance for Manufacturers
6.5.1 Benelux Diabetes Insulin Pen Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Benelux Diabetes Insulin Pen Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Benelux Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Benelux Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 Italy Market Performance for Manufacturers
6.6.1 Italy Diabetes Insulin Pen Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 Italy Diabetes Insulin Pen Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 Italy Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 Italy Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Spain Market Performance for Manufacturers
6.7.1 Spain Diabetes Insulin Pen Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Spain Diabetes Insulin Pen Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Spain Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Spain Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 Market Performance for Manufacturers
6.8.1 Diabetes Insulin Pen Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 Diabetes Insulin Pen Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 Diabetes Insulin Pen Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 Diabetes Insulin Pen Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Europe Diabetes Insulin Pen Market Performance (Sales Point)
7.1 Europe Diabetes Insulin Pen Sales (K Units) and Market Share by Regions 2014-2020
7.2 Europe Diabetes Insulin Pen Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Europe Diabetes Insulin Pen Price (USD/Unit) by Regions 2014-2020
7.4 Europe Diabetes Insulin Pen Gross Margin by Regions 2014-2020
8 Development Trend for Regions (Sales Point)
8.1 Europe Diabetes Insulin Pen Sales and Growth, Sales Value and Growth Rate2014-2020
8.2 Germany Diabetes Insulin Pen Sales and Growth, Sales Value and Growth Rate2014-2020
8.3 UK Diabetes Insulin Pen Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 France Diabetes Insulin Pen Sales and Growth, Sales Value and Growth Rate2014-2020
8.5 Russia Diabetes Insulin Pen Sales and Growth, Sales Value and Growth Rate2014-2020
8.6 Benelux Diabetes Insulin Pen Sales and Growth, Sales Value and Growth Rate2014-2020
8.7 Italy Diabetes Insulin Pen Sales and Growth, Sales Value and Growth Rate2014-2020
8.8 Spain Diabetes Insulin Pen Sales and Growth, Sales Value and Growth Rate2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Distributors
11 Consumer Analysis
11.1 Hospital Industry
11.2 Household Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Europe Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Europe Diabetes Insulin Pen Sales (K Units) and Growth Rate 2021-2026
12.1.3 Germany Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 UK Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 France Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Russia Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Benelux Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 Italy Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Spain Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units) and Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Disposable Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2.3 Reusable Diabetes Insulin Pen Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.3 Sales Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Hospital Sales and and Growth Rate 2021-2026
12.3.3 Household Sales and and Growth Rate 2021-2026
12.4 Price (USD/Unit) and Gross Profit Forecast
12.4.1 Europe Diabetes Insulin Pen Price (USD/Unit) Trend 2021-2026
12.4.2 Europe Diabetes Insulin Pen Gross Profit Trend 2021-2026
13 Conclusion


Europe Industrial Protective Clothing Market 2024...

Industrial protective clothing constitutes specialized attire fabricated from engineered textiles intended to safeguard personnel operating amid potentially perilous occupational environments from exposure to myriad hazards inherent to industrial settings such as manufacturing plants, construction s...

Tubeless Insulin Pumps (Patch Pumps) Market Size And Share Analysis - Growth Trends And Forecasts (2024-2031)...

The Tubeless Insulin Pumps (Patch Pumps) Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...

Global Glucagon-Like Peptide 1 (GLP-1) Agonist market (2024 Edition): Analysis by Type (Tirzepatide, Semaglutide, Dulaglutide, Others), End-Use (Type 2 Diabetes, NASH, Obesity), By Distribution Channel, By Route of Administration, By Region, By Country: Market Insights and Forecast (2020-2030)...

Executive Summary Azoth Analytics has released a research report titled "Global Glucagon-Like Peptide 1 (GLP-1) Agonist Market (2024 Edition)" which provides a complete analysis of the Global Glucagon-Like Peptide 1 (GLP-1) Agonist industry in terms of market segmentation By Type (Tirze...

Europe Cutting Tools Market 2023-2033 by Tool Type (Solid Round, Indexable), Product (Groovers, Reamers, Milling Cutters, Drills), Material (Cemented Carbide, HSS, Ceramics, CBN), Chip Breaker (Step, Ridge, Universal, Separate), Application, Industry Vertical, Distribution Channel (Offline, Online), and Country: Trend Forecast and Growth Opportunity...

Europe cutting tools market was valued at $6.85 billion in 2023 and will grow by 4.6% annually over 2023-2033. The growth is driven by the increasing production and manufacturing activities, improved operational efficiency and innovative design, and an increasing demand for power tools for DIY activ...

Europe Paper Machine Clothing (PMC) Market 2023-2033 by Product Type (Forming Fabrics, Press Felts, Dryer Fabrics), Material (Nylon, Polyester, PVDF, Others), Application (Wrapping & Packaging Paper, Printing & Writing Paper, Household & Sanitary Paper, Newsprint, Others), and Country: Trend Forecast and Growth Opportunity...

Europe paper machine clothing (PMC) market was valued at $ 631.1 million in 2023 and will grow by 3.6% annually over 2023-2033. The growth is driven by the increasing demand for paper and paper-based products across various industries, technological advancements in the papermaking process, the intro...

Europe Endoscopy Devices Market 2023-2033 by Device Type, Hygiene, Application, End User, and Country: Trend Forecast and Growth Opportunity...

Europe endoscopy devices market was valued at $10.1 billion in 2023 and will grow by 5.9% annually over 2023-2033. The growth is driven by the increasing prevalence of chronic diseases, the growing demand for less invasive procedures, a rising adoption of disposable endoscopic components, growing ge...

Europe Digital Health and Wellness Market 2023-2033 by Product (Hardware, Solutions), Category (Health, Wellness), Connectivity (Cellular, NFC, Bluetooth, Wi-Fi), End User (Hospitals & Clinics, ASCs, Homecare & Individuals), Age Group (Pediatric, Adults, Geriatric), Distribution Channel (Online, Specialty Stores, Department Stores, Hypermarket), and Country: Trend Forecast and Growth Opportunity...

Europe digital health and wellness market was valued at $100.9 billion in 2023 and will grow by 18.9% annually over 2023-2033. The growth is driven by an increasing number of chronic diseases, the growing investment in health and wellness programs, the increased use of smartphones and wearable devic...

Europe Connected Healthcare Device Market 2023-2033 by Product (Medical Devices, Wellness Devices, Software & Services), Device Type (Wearable, Implantable, Stationary), Application (Remote Monitoring, Consultation and Diagnosis, Treatment, Fitness and Wellness), End User (Hospitals, Clinics, ASCs, Home Care), and Country: Trend Forecast and Growth Opportunity...

Europe connected healthcare device market was valued at $16 billion in 2023 and will grow by 19.2% annually over 2023-2033. The growth is driven by the emergence of telehealth and telemedicine services, benefits such as reliability and effective patient monitoring, the penetration of mobile and inte...

Europe Bioprocess Technology Market 2023-2033 by Product (Instruments, Consumables and Accessories), Process (Upstream, Downstream), Procedure, Application (Recombinant Proteins, Antibiotics, Biosimilars, mAbs, Others), End User (Biopharma Companies, CMOs, Institutes, CROs), and Country: Trend Forecast and Growth Opportunity...

Europe bioprocess technology market was valued at $6.56 billion in 2023 and will grow by 13.7% annually over 2023-2033. The growth is driven an increasing prevalence of chronic diseases, the widespread use of bioprocess technology, rising expenditures on R&D in the biotechnology sector, ongoing tech...

Europe Biopharmaceuticals Market 2023-2033 by Product Type, Testing Service, Raw Material (Excipients, API, Others), Classification (Innovative, Biogenerics and Biosimilars), Therapeutic Area, and Country: Trend Forecast and Growth Opportunity...

Europe biopharmaceuticals market was valued at $116.5 billion in 2023 and will grow by 8.6% annually over 2023-2033, driven by the prevalence of chronic diseases along with aging population, rising investments in novel biopharma drugs, technological advancement for drug discovery, growing clinical t...